Physician profile
Steven Shoemaker
NPI 1841476397
$632.97
in general payments reported to CMS, 2019-2025
12 companies · $50.57 in 2025
The $50.57 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $14.11 · 2021: $44.53 · 2022: $236 · 2023: $120 · 2025: $50.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $183.94 | 2019-2023 | Physio-Stim |
| Organogenesis INC. | $117.66 | 2020-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $71.69 | 2019-2021 | |
| Sequoia Surgical, INC. | $50.00 | 2019 | |
| Smith+Nephew, INC. | $48.27 | 2022-2025 | Renasys |
| Paratek Pharmaceuticals, INC. | $47.52 | 2022-2025 | Nuzyra |
| Dynasplint Systems INC. | $35.36 | 2019 | |
| Treace Medical Concepts, INC. | $18.05 | 2022 | |
| Terumo Bct, INC. | $16.84 | 2019 | |
| Grt US Holding, INC. | $16.21 | 2022 | |
| Tei Medical INC. | $15.07 | 2019 | |
| Kci USA, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Shoemaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.